Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Sep;34(1-2):30-1.
doi: 10.1007/BF01993229.

Effects of the prostaglandin analogue misoprostol on inflammatory mediator release by human monocytes

Affiliations

Effects of the prostaglandin analogue misoprostol on inflammatory mediator release by human monocytes

D L Widomski et al. Agents Actions. 1991 Sep.

Abstract

The effect of misoprostol (M) on IL-1 beta, TNF-alpha, and lipid mediator release (assessed by RIA) by adherent (assessed by electron microscopy) human monocytes were studied in vitro. Human monocytes stimulated with E. Coli-derived lipopolysaccharide showed an increase in both IL-1 beta and TNF-alpha release. Incubation of the monocytes with LPS and M (18 hrs.), resulted in a reduction of both IL-1 beta and TNF-alpha levels. Leukotriene B4 levels did not increase in response to LPS or M. LPS also caused an increase in thromboxane (TXB2). M decreased TXB2 levels. 6-keto PGF1 alpha (6KP). Incubation with LPS and M stimulated release. LPS caused an increase in PGE2 levels. M (100 microM) caused an increase in PGE2 levels, M (1 microM) had no effect on PGE2. These data suggest a possible immunomodulatory role for misoprostol in inflammatory diseases.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Agents Actions. 1989 Jun;27(3-4):274-6 - PubMed
    1. Med Res Rev. 1990 Apr-Jun;10(2):149-72 - PubMed
    1. Trends Pharmacol Sci. 1990 Aug;11(8):301-4 - PubMed
    1. J Immunol. 1979 Apr;122(4):1228-36 - PubMed
    1. Proc Natl Acad Sci U S A. 1989 May;86(10):3803-7 - PubMed